Prostate cancer patients with metastatic disease and low-volume primary tumors appear to have a poor prognosis, according to ...

University Hospitals Seidman Cancer Center researchers have developed a tool that could identify metastatic prostate cancer ...

Cribriform-negative disease had a low metastasis rate unaffected by treatment. After radiation therapy with neoadjuvant ADT group, men with cribriform-positive disease had the same metastasis rate as ...

A life-extending prostate cancer drug is to be made available to thousands of men in England in a matter of weeks, after a ...

Medically reviewed by Matthew Wosnitzer, MD Key Takeaways Metastatic castration-resistant prostate cancer is an advanced form ...

A 68-year-old man presented to the emergency department with haematuria and penile pain. His medical history included benign prostatic hyperplasia, but no follow-up examinations had been performed.

A new study published in Nature Communications provides a framework for researching whether earlier, model-guided treatment ...

Thousands of men battling prostate cancer are set to gain access to a life-extending drug on the NHS following a significant ...

The decision means Northern Ireland remains the only country in the UK where patients with this stage of prostate cancer are ...

NHS England has announced that men whose high-risk prostate cancer has not yet spread will be able to receive the drug, ...

Advanced prostate cancer cases are rising worldwide as fewer men undergo routine PSA screening and early symptoms go ...

Thousands of men with prostate cancer will be offered a life-extending drug on the NHS within weeks. For the first time patients whose prostate cancer has not spread will be able to receive the drug ...